Could potato starch help liver patients think clearly?
NCT ID NCT06425380
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study at Mayo Clinic is testing whether a dietary supplement called resistant potato starch can change gut bacteria in people with cirrhosis who have had episodes of confusion (hepatic encephalopathy). Eleven participants will take 20 grams of potato starch twice daily for 4 weeks. Researchers will measure changes in stool short-chain fatty acids and a simple animal-naming test to see if the starch affects brain function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Resistant potato starch (Bob's Red Mill® potato starch)
- What this could lead to
- If it works, this could point toward a simple dietary supplement to help manage hepatic encephalopathy by improving gut health.
- What could go wrong
- This is a very small pilot study with only 11 people and no placebo group. It is designed to see if the starch changes gut bacteria, not to prove it treats symptoms. Results may not lead to a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55902, United States
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Can tracking hospital care for liver patients reduce repeat admissions?
- Heart scans could uncover silent damage in liver patients awaiting transplant